UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of the anti–PD-L1 monoclonal antibody socazolimab for recurrent or metastatic cervical cancer: Results from the phase I dose-escalation and expansion study

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5526-5526

2022

Volltextzugriff (PDF)

Prospective Study of Tailoring Whole-Body Dual-Modality [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging

Journal of clinical oncology, 2013-08, Vol.31 (23), p.2861-2869

2013

Volltextzugriff (PDF)

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3065-3076

2022

Volltextzugriff (PDF)

Deep learning analysis of the adipose tissue and the prediction of prognosis in colorectal cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.139-139

2022

Volltextzugriff (PDF)

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Journal of clinical oncology, 2012-02, Vol.30 (4), p.419-425

2012

Volltextzugriff (PDF)

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1163-1173

2022

Volltextzugriff (PDF)

Crosstalk between the MSI status and tumor microenvironment in colorectal cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e15236-e15236

2020

Volltextzugriff (PDF)

High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3043-3043

2024

Volltextzugriff (PDF)

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

Journal of clinical oncology, 2016-05, Vol.34 (13), p.1448-1454

2016

Volltextzugriff (PDF)

ZFHX4 mutation as a novel predictive biomarker for immune checkpoint blockade in non-small cell lung cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e20535-e20535

2022

Volltextzugriff (PDF)

A novel molecular subtype of hepatocellular carcinoma based on the tumor purity and tumor microenvironment-related polygenic risk scores

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e15040-e15040

2022

Volltextzugriff (PDF)

Penpulimab plus platinum-based chemotherapy combined with anlotinib in first-line treatment for persistent, recurrent, or metastatic cervical cancer: A single-arm, open-label phase Ⅱ study (ALTN-AK105-II-06)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17512-e17512

2023

Volltextzugriff (PDF)

HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.1021-1021

2023

Volltextzugriff (PDF)

Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16103-e16103

2020

Volltextzugriff (PDF)

Anlotinib plus toripalimab as first-line treatment for patients with unresectable hepatocellular carcinoma: Updated results of the ALTER-H003 trial

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.568-568

2023

Volltextzugriff (PDF)

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

Journal of clinical oncology, 2023-01, Vol.41 (2), p.343-353

2023

Volltextzugriff (PDF)

Phase Ib/IIa safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced solid tumors

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2536-2536

2023

Volltextzugriff (PDF)

Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.6068-6068

2022

Volltextzugriff (PDF)

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study

Journal of clinical oncology, 2023-04, Vol.41 (10), p.1898-1908

2023

Volltextzugriff (PDF)

The ratio of PD1+CD8+T cells in stromal area of tumor tissue is associated with the effect of neoadjuvant chemotherapy in HER2 negative breast cancer patients

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12626-e12626

2022

Volltextzugriff (PDF)

Differences in tumor microenvironment between HER2-positive and HER2-negative breast cancer

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e12562-e12562

2022

Volltextzugriff (PDF)

Updated results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.446-446

2022

Volltextzugriff (PDF)

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study

Journal of clinical oncology, 2021-10, Vol.39 (28), p.3161-3170

2021

Volltextzugriff (PDF)

Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems

Journal of clinical oncology, 2017-01, Vol.35 (3), p.274-280

2017

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

Zeitschrift / SerieJournal Of Clinical Oncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(106)
Mit Volltextzugriff
(97)

Publikationsform

Artikel
(106)

Sprache

Englisch
(106)

Erscheinungsjahr

n.n

Kollektion

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of the anti–PD-L1 monoclonal antibody socazolimab for recurrent or metastatic cervical cancer: Results from the phase I dose-escalation and expansion study

Prospective Study of Tailoring Whole-Body Dual-Modality [18F]Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography With Plasma Epstein-Barr Virus DNA for Detecting Distant Metastasis in Endemic Nasopharyngeal Carcinoma at Initial Staging

Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III Study

Deep learning analysis of the adipose tissue and the prediction of prognosis in colorectal cancer

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial

Crosstalk between the MSI status and tumor microenvironment in colorectal cancer

Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

High-sensitive multi-cancers early detection for 8 cancer types by cell-free DNA targeted methylation sequencing: A retrospective cohort study

Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction

ZFHX4 mutation as a novel predictive biomarker for immune checkpoint blockade in non-small cell lung cancer

A novel molecular subtype of hepatocellular carcinoma based on the tumor purity and tumor microenvironment-related polygenic risk scores

Penpulimab plus platinum-based chemotherapy combined with anlotinib in first-line treatment for persistent, recurrent, or metastatic cervical cancer: A single-arm, open-label phase Ⅱ study (ALTN-AK105-II-06)

HER2-low status discordance between primary and recurrent/metastatic breast cancer in a large-scale cohort

Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer

Anlotinib plus toripalimab as first-line treatment for patients with unresectable hepatocellular carcinoma: Updated results of the ALTER-H003 trial

Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

Phase Ib/IIa safety and efficacy of PM8002, a bispecific antibody targeting PD-L1 and VEGF-A, as a monotherapy in patients with advanced solid tumors

Neoadjuvant chemotherapy plus tislelizumab followed by concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A single-arm, phase II trial

Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study

The ratio of PD1+CD8+T cells in stromal area of tumor tissue is associated with the effect of neoadjuvant chemotherapy in HER2 negative breast cancer patients

Differences in tumor microenvironment between HER2-positive and HER2-negative breast cancer

Updated results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma

Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study

Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems

Aktive Filter

Suchergebnisse filtern